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Many cerebral cortical neurons and glia are produced by apical progenitors dividing at the ventricular surface of the embryonic dorsal
telencephalon. Other neurons are produced by basal progenitor cells, which are derived from apical progenitors, dividing away from the
ventricular surface. The transcription factor Pax6 is expressed in apical progenitors and is downregulated in basal progenitors, which upregulate
the transcription factor Tbr2. Here we show that Pax6−/− cells are under-represented in the cortex of Pax6+/+↔Pax6−/− chimeras early in
corticogenesis, indicating that Pax6 is required for the production of normal numbers of cortical cells. We provide evidence that this
underproduction is attributable to an early depletion of the progenitor pool caused by greater than normal proportions of newly divided cells
exiting the cell cycle. We show that most progenitor cells dividing away from the ventricular surface in Pax6−/− embryos fail to express the
transcription factor Tbr2 and that Pax6 is required cell autonomously for Tbr2 expression in the developing cortex of Pax6+/+↔Pax6−/− chimeras.
Transcription factors normally expressed ventrally in the telencephalic ganglionic eminences (Mash1, Dlx2 and Gsh2) are upregulated cell
autonomously in mutant cells in the developing cortex of Pax6+/+↔Pax6−/− chimeras; Nkx2.1, which is expressed only in the medial ganglionic
eminence, is not. These data indicate that early functions of Pax6 in developing cortical cells are to repress expression of transcription factors
normally found in the lateral ganglionic eminence, to prevent precocious differentiation and depletion of the progenitor pool, and to induce normal
development of cortical basal progenitor cells.
© 2006 Elsevier Inc. Open access under CC BY license.Keywords: Chimera; Pax6; Proliferation; Telencephalon; Mouse; Tbr2; Mash1; Nkx2.1; Gsh2; Dlx2; Apical progenitor cell; Basal progenitor cellIntroduction
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requires control of two key aspects of proliferation: (i) the
length of the cell cycle and (ii) the proportion of newly
generated cells that re-enter the cell cycle as opposed to
leaving it to differentiate. A number of cell cycle regulators
and transcription factors, including Pax6, have been impli-
cated in the control of these processes (Calegari and Huttner,
2003; Estivill-Torrus et al., 2002; Heins et al., 2002; Iacopetti
et al., 1999; Roy et al., 2004). Two types of progenitor cell
exist in the developing neocortex. Radial glia, also known as
apical progenitor cells (APCs), divide at the ventricular
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offspring, or asymmetrically to produce one mitotic and one
postmitotic daughter [for review see Fishell and Kriegstein,
2003]. A second proliferative population, derived from the
APCs, forms in the subventricular zone: the majority of these
cells divide symmetrically to produce two postmitotic
neurons, and they have been designated non-surface dividing
cells or basal progenitor cells (BPCs) (Haubensak et al., 2004;
Miyata et al., 2004; Noctor et al., 2004; Smart, 1976;
Takahashi et al., 1995b). BPCs are thought to generate many
of the neurons in the upper cortical layers (Altman and Bayer,
1990; Tarabykin et al., 2001). Pax6 is expressed in APCs and
is downregulated in BPCs (Englund et al., 2005) and, in the
present study, we addressed unanswered questions about the
functions of Pax6 in the development of these cell types so as
to generate a coherent model of the early functions of Pax6 in
cortical development.
First, we examined how the overall production of Pax6−/−
cortical cells compared to that of Pax6+/+ cells early in cor-
ticogenesis. The fact that the dorsal telencephalon of Pax6−/−
embryos is smaller than that of wild types is not sufficient
evidence for underproduction since it does not exclude the
possibility that cells are more densely packed in the mutants,
which is certainly the case in the later stages of corticogenesis
(Caric et al., 1997; Kroll and O'Leary, 2005; Schmahl et al.,
1993). We examined the production of Pax6−/− cells in the
cortex of Pax6+/+↔Pax6−/− chimeras, allowing us to compare
the numbers of cells with the two genotypes in the same animals
and to test whether abnormalities persist even in the presence of
wild-type cells, i.e., whether they likely reflect a cell
autonomous requirement for Pax6. The results showed reduced
production of mutant cells in our chimeras. We then
investigated whether Pax6 is required to prevent excessive
cell death, to regulate the length of the cortical progenitor cell
cycle or to control the proportion of newly generated cells that
re-enter the cell cycle as opposed to leaving it to differentiate.
We found that the last of these parameters was altered in the
Pax6−/− cortex, indicating that Pax6 expression is required to
maintain the size of the cortical progenitor pool. Next, we
examined the BPCs in Pax6−/− embryos. A recent study
(Englund et al., 2005) showed that BPCs express the
transcription factor Tbr2. The number of progenitors dividing
away from the ventricular zone (or abventricularly) is increased
in Pax6−/− mutants (Estivill-Torrus et al., 2002; Haubst et al.,
2004).We tested whether these cells resemble normal BPCs in
expressing Tbr2 and found that the majority of abventricular
mitoses in the Pax6−/− mutant cortex did not express Tbr2.
Since Pax6 is normally expressed in APCs and downregulated
in BPCs, we determined whether Pax6 is required cell
autonomously for Tbr2 expression using Pax6+/+↔Pax6−/−
chimeras.
The dorsal telencephalon of Pax6−/− mutants becomes
progressively ventralized throughout corticogenesis and this is
due to a change in the fate of dorsal telencephalic progenitors
(Kroll and O'Leary, 2005). What remains unclear is whether
this fate change is a direct cell autonomous consequence of
the loss of Pax6 in cortical progenitors or whether it resultsindirectly from a loss of Pax6 in interacting cells. We
addressed this issue by examining the expression of ventral
genes in mutant cells in the cortex of Pax6+/+↔Pax6−/−
chimeras.
Methods
Production of Pax6+/+↔Pax6−/− chimeras
Chimeras used to estimate the numbers of mutant cells contributing to the
cortex were produced as described in Quinn et al. (1996). In brief, eight-cell
embryos were obtained from the parental cross Pax6Sey-Neu/+, Gpi1b/b
female×Pax6+/Sey, Gpi1b/b, Tg/Tg male, where Tg denotes the presence of the
reiterated β-globin transgene TgN(Hbb-b1)83Clo (Keighren andWest, 1993; Lo
et al., 1987). Embryos of the following four genotypes were obtained from this
parental cross: Pax6+/+, Pax6Sey-Neu/+, Pax6+/Sey and Pax6Sey-Neu/Sey, all of
which wereGpi1b/b and contained a single copy of the β-globin transgene (Tg+).
Donor embryos for aggregation were obtained from (BALB/c x A/J) F2
intercrosses, producing embryos that were Pax6+/+, Gpi1a/a and negative for the
β-globin transgene (Tg−). Embryos were collected from superovulated females
at 2.5 days post coitum and aggregated according to West and Flockhart (1994).
Aggregated embryos were cultured overnight, transferred to recipient pseudo-
pregnant F1 females (Pax6+/+, Gpi1c/c, Tg−).
To increase the efficiency of return of Pax6+/+↔Pax6−/− chimeras for
subsequent studies of the identities of Pax6−/− cells, we derived Pax6−/− mutant
embryonic stem (ES) cells from mice on an inbred 129/Sv background that were
hemizygous for the β-globin transgene TgN(Hbb-b1)83Clo (Keighren and
West, 1993;Loet al., 1987) (designated 129SeyD). 129SeyD1 ES cells (Pax6−/−,
Gpi1a/a, Tg+) were injected into (C57Bl/6 x CBA/Ca) F2 intercross blastocysts
(Pax6+/+, GpiIb/b, Tg−), which were transferred to the uterus of a pseu-
dopregnant recipient and allowed to develop to the appropriate embryonic
stage.
Fetuses were dissected into cold PBS and staged according to forelimb
development (Palmer and Burgoyne, 1991; Wanek et al., 1989). Tail and
forelimb samples were taken for analysis of glucose phosphate isomerase
(GPI1) isotype contribution to give a proportion of global chimerism for each
embryo (West and Flockhart, 1994). A mean percentage GPI1 was
determined to give the proportion of cells in the chimera derived from the
Pax6Sey-Neu/+×Pax6+/Sey 8-cell embryo or 129SeyD1 ES cells. The genotype
of each chimera was determined by PCR and restriction digest analysis of
genomic DNA as described previously (Quinn et al., 1996). The use of two
predicted null mutant Pax6 alleles, Pax6Sey and Pax6Sey-Neu (Hill et al., 1991),
allowed distinction between aggregation chimeras containing Pax6Sey-Neu/Sey
compound heterozygous (described here as Pax6−/−) cells and those
containing Pax6Sey-Neu/+ or Pax6+/Sey heterozygous (described as Pax6+/-)
cells. Chimeric embryos obtained by ES cell injection were genotyped for the
presence of the Pax6Sey allele alone. Histological visualization of cells
derived from the Pax6Sey-Neu/+×Pax6+/Sey embryos or from 129SeyD1 ES
cells was achieved by DNA–DNA in situ hybridization using a digoxigenin-
labeled probe to the reiterated β-globin transgene (Keighren and West, 1993;
Quinn et al., 1996). Detection of in situ signal was achieved either with
peroxidase-labeled antibody visualized with diaminobenzidine (DAB)
(Keighren and West, 1993) or by reaction with an anti-digoxigenin rhoda-
mine antibody (Roche). We observed no phenotypic differences between
Pax6+/+↔Pax6−/− chimeras obtained by aggregation or ES cell injection.
Quantitative analysis of contribution of Pax6−/− cells to
Pax6+/+↔Pax6−/− chimeras
Percentages of Tg+ cells in various regions of the forebrain and other tissues
of E12.5 chimeras were measured in a minimum of three non-consecutive
sections, with 300–700 cells counted per area per section, depending on tissue.
As in previous studies (Quinn et al., 1996), observed percentages for each tissue
(O) were corrected to allow for failure to identify Tg+ signals in all Tg+ cells due
to sectioning artefact. To generate tissue-specific correction factors (c),
percentages of Tg+ nuclei in Pax6+/+, Tg+ embryos (i.e., non-chimeric embryos
in which all cells should be Tg+) were counted at E12.5. Corrected observed
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divided by the percentage of cells expected in that tissue (E) if the percentage was
to equal the global percentage chimerism estimated by GPI1B analysis (Oc/E).
Values were compared by Student's t-test.
Production of Pax6−/− mice
All non-chimeric mouse embryos designated Pax6−/− were derived from
Pax6Sey heterozygote crosses maintained on an inbred Swiss background. Wild-
type siblings were used as controls. The day of the vaginal plug following
mating was designated E0.5. Pregnant females were killed by cervical
dislocation. Fetuses were dissected from the uterus at the required gestational
age before fixing and processing to either wax or plastic sections. Wax sections
were cut at 10 μm and plastic sections at 5 μm.
Quantitative analysis of cell densities and cortical depth
In all cases, images were captured using Leica NTS confocal microscopy.
Areas for cell density analysis were defined using Image-Tool™. Cells were
counted on a minimum of 5 non-consecutive sections at E12.5. Cell counts/
densities were compared using Sigmastat™. Cortical depths were measured in the
center of the neocortex using Image Tool and data compared using Sigmastat™.
Studying cell cycle with iododeoxyuridine (IdU) and
bromodeoxyuridine (BrdU)
On embryonic day E10.5 or E12.5, IdU was injected i.p. into pregnant
dams followed by BrdU injection (both at 70 μg/g body weight) 1.5 h later
(Fig. 2A). Dams were killed at 2.0 h after the first injection; embryos were
fixed, sectioned and processed to reveal IdU/BrdU using mouse monoclonal
anti-BrdU (Becton Dickson Ltd., UK), which recognized both IdU and
BrdU, in conjunction with rat monoclonal anti-BrdU (Abcam Ltd., UK)
which recognized BrdU alone. Directly conjugated AlexaFluor® secondary
antibodies were anti-mouse AlexaFluor® 488 and anti-rat AlexaFluor® 568.
Images were captured using Leica NTS confocal microscope, viewed using
LCS Lite (Leica) and imported into Adobe Photoshop for counting.
Proportions of IdU/BrdU-labeled cells in the ventricular zone of telencepha-
lon were counted in a minimum of three (E10.5) or five (E12.5) non-
adjacent sections from each embryo. Cell cycle lengths were calculated using
the following paradigm (Martynoga et al., 2005): cells in the initial IdU-
labeled cohort that leave S-phase during the interval between IdU and BrdU
(Ti=1.5 h), designated the leaving fraction (Lcells), will be labeled with IdU
but not BrdU. The proportion of cells labeled with BrdU is designated Scells.
The length of S-phase (Ts) can be calculated using the formula:
Ts
1:5
¼ Scells
Lcells
and the length of the cell cycle (Tc) estimated from the formula:
Tc
Ts
¼ Pcells
Scells
where Pcells is the total number of proliferating cells in the ventricular zone
(VZ) (Martynoga et al., 2005). Since previous studies have shown that a
prolonged pulse of BrdU will label virtually all VZ cells at E12.5, in both
wild-type and Pax6−/− embryos, Pcells was estimated by counting all VZ cells
(Estivill-Torrus et al., 2002).
Cumulative BrdU analyses
BrdU was given (70 μg/g body weight, i.p.) to E12.5 pregnant dams either
once or every 2 h over a 12-h period. Dams were killed 0.5 and 12.5 h after the
first injection; embryos were fixed, sectioned and processed to reveal BrdU as
described previously (Gillies et al., 1990). The relative intensity of BrdU label in
the nucleus of each BrdU-labeled cell in three 200-μm-wide strips through the
cortex, in three non-adjacent sections from each embryo, was measured using a
Leica digital camera and QWin (Leica) software.Immunocytochemistry on cortical cells
Cells from E12.5 neocortex of Pax6+/+ and Pax6−/− embryos were
dissociated using papain as per manufacturer's instructions (Papain Dissociation
System, Worthington Biochemicals, UK) and stained for β-tubulin isotype III
(mouse monoclonal IgG2b, 1:100, Sigma, UK). Visualization was achieved
using directly conjugated AlexaFluor® 488 (goat anti-mouse IgG, 1:200) or
AlexaFluor® 546 (goat anti-mouse IgG, 1:200) (Molecular Probes, Inc.). For
cell counts, 800–1500 viable cells per culture were assessed in six randomly
selected microscope fields.
Flow cytometric analysis of cortical cells
Cortices were dissociated as above and fixed in ice cold 70% ethanol.
Cortical tissue was collected from E12.5 and E14.5 embryos from 4 separate
litters and a minimum of 3 individuals of each genotype pooled at dissection.
Dissociated cells were stained for β-tubulin isotype III (1:800); primary
antibody binding was revealed using directly conjugated AlexaFluor® 488
(1:800) as above. Cells were then stained with propidium iodide (PI) to allow
discrimination of single cells and analysis of DNA content. Staining reactions
were carried out in duplicate. Cells were analyzed on a Beckman-Coulter XL
flow cytometer with Expo32 software (Beckman-Coulter, Inc.). 8000–20,000
cells were analyzed per sample.
Cell death analysis
Cells from E12.5 neocortex of Pax6+/+ and Pax6−/− fetuses were dissociated
and cultured for 24 h as described previously (Estivill-Torrus et al., 2002).
Cultures contained cells of either genotype alone or both genotypes mixed, with
one set of cells stained using PKH26 fluorescent cell linker (Sigma) according to
the manufacturer's instructions. Cells were fixed with 4% paraformaldehyde and
visualized for localization of activated caspase-3 using rabbit polyclonal anti-
caspase-3 antibody (Chemicon International; 1:100). Secondary amplification
was with anti-rabbit biotin-conjugated antibody (DAKO; 1:200) and visualiza-
tion was with streptavidin-conjugated AlexaFluor® 488 (Molecular Probes;
1:200). Cells were counterstained with bisbenzimide. Apoptotic cells were
identified either by immunoreactivity for activated caspase-3 activity (Lesuisse
and Martin, 2002; Srinivasan et al., 1998) and/or nuclear chromatin
condensation, as described previously (Kerr et al., 1972). Cell counts were
done in six randomly selected microscope fields per culture.
Microarray hybridization
Total RNA from E14.5 neocortex was isolated using a method based on
guanidinium lysis and phenol–chloroform extraction (ToTALLY RNA,
Ambion). Labeling of total RNAwas performed using the dendrimer technology
(3DNA Submicro Expression Array Detection Kit, Genisphere). The cDNAwas
then hybridized to a cDNA chip representing 1026 different genes of the TESS
subtractive cDNA library (Faedo et al., 2004) which had been generated by
subtracting genes expressed in adult telencephalon from those expressed in
E14.5 cortex (Porteus et al., 1992). Differential gene expression was assessed by
scanning the hybridized arrays as described previously (Faedo et al., 2004).
Changes in Tbr2 gene expression were confirmed at a protein level by Western
blotting for Tbr2 protein expression using standard protocols. Equal loading of
lanes was confirmed using β-actin immunostaining.
Immunohistochemistry
Embryos were fixed overnight in 4% paraformaldehyde/PBS and processed
to wax. All embryos were sectioned in the coronal plane. Slides were
microwaved in 10 mM sodium citrate to achieve maximal antigen retrieval
before addition of primary antibody. Antibodies used were mouse monoclonal
anti-β-tubulin isotype III (Sigma, UK), mouse anti-phosphohistone 3 (Abcam
Ltd., UK), rabbit polyclonal Tbr2 (Englund et al., 2005), mouse anti-Mash1 (BD
Biosciences), rabbit anti-Dlx2 antibody (Abcam Ltd., UK), anti-Gsh2 (Toresson
et al., 2000), anti-Nkx2.1 (Biopat) and directly conjugated AlexaFluor®
secondary antibodies (Molecular Probes). Nuclei were stained with TOPRO3
Fig. 1. Pax6−/− cells are under-represented in the telencephalon of E12.5
Pax6−/−↔Pax6+/+ chimeras. Plastic embedded sections of (A) Pax6+/+ and (B)
Pax6−/− E12.5 cortex. Boxed area in panel A is an enlargement of preplate of
wild-type neocortex showing a cell undergoing mitosis (closed arrowhead) next
to a cell undergoing apoptosis (open arrowhead). Mitotic figures were seen at the
ventricular surface and at subventricular locations in both Pax6+/+ and Pax6−/−
cortex (e.g., arrow in panel B). (C) Pax6 protein localization in the E12.5Pax6+/+
telencephalon. Pax6 is expressed in a highlateral to lowmedial gradient in the
ventricular zone of the developing neocortex (ctx), hippocampus (h) and dorsal
lateral ganglionic eminence (dLGE). (D) High power image of medial
telencephalon showing boundary of Pax6 expression between hippocampus
and cortical hem (ch). (E) Pax6−/−↔Pax6+/+ chimera (with a global contribution
of 53% Pax6−/−, Tg+ cells determined by GPI1 analysis) showing under-
representation of Pax6−/−, Tg+ cells (brown spots in nucleus) in the Pax6-
expressing hippocampus but not in the cortical hem. (F) Composition of
telencephalic regions of E12.5 Pax6+/+↔Pax6+/+ and Pax6−/−↔Pax6+/+
chimeras. Mean ratios±SEM of corrected percentages of Tg+ cells in each
tissue to global GPI1B percentage in the embryo (Oc/E) are shown for both
Pax6+/+↔Pax6+/+ (light bars) and Pax6−/−↔Pax6+/+ (dark bars) chimeras. At
E12.5, there is a significant reduction in the number of Pax6−/− cells con-
tributing to hippocampus (Student's t-test, p<0.001), neocortex (p<0.03) and
dLGE (p<0.02) in Pax6−/−↔Pax6+/+ (dark bars) chimeras. Significant
differences are marked with an asterisk (*). Scale bars: (A, B)=20 μm,
(C)=200 μm, (D)=100 μm, (E)=50 μm.
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either Dako ABC or Dako Envision Kit prior to staining with DAB.
Results
Cortical thickness is reduced at E12.5 in the Pax6−/− mutant
embryo
A reduction in cortical thickness is a reported feature of the
homozygous Pax6−/− telencephalic phenotype during mid-late
corticogenesis (Caric et al., 1997; Fukuda et al., 2000; Haubst et
al., 2004; Schmahl et al., 1993; Warren et al., 1999). To
determine whether reduction had occurred by E12.5, we
measured thickness in the center of the neocortex of Pax6−/−
embryos and their wild-type siblings. Neocortical thickness was
significantly reduced in Pax6−/− embryos (Pax6+/+cortex:
mean cortical depth 135 μm±6.2, SEM; Pax6−/− cortex:
mean cortical depth 114 μm±7.1, SEM; n=9 in both cases;
Student's t-test, p<0.05).
Pax6−/− cells are under-represented in the dorsal
telencephalon of E12.5 Pax6−/−↔Pax6+/+ chimeric mice
To directly compare Pax6−/− and Pax6+/+ cell production in
vivo, we created Pax6−/−↔Pax6+/+ chimeras. There are two
advantage of this approach. First, it allows a direct comparison
of the productivity of mutant and wild-type cells in the same
embryo. Second, abnormalities in the production of Pax6−/−
cells in chimeras are attributable to a cell autonomous
requirement for Pax6 in progenitors (Pratt et al., 2002; Quinn
et al., 1996; Talamillo et al., 2003). In Pax6−/− embryos, an
absence of Pax6 could affect progenitors indirectly, as a
consequence of a primary effect on other cells (a cell non-
autonomous effect), but this is less likely in chimeras where
mutant cells can interact with wild-type cells.
We generated chimeras in which a β-globin transgene
(designated Tg) labels one of the two sets of cells used to make
the chimeras (Pax6−/− cells in Pax6−/−↔Pax6+/+ chimeras or
one set of Pax6+/+ cells in Pax6+/+↔Pax6+/+ control
chimeras). Telencephalic regions known to express Pax6 in
wild-type embryos were examined (Figs. 1C, D). Observation
of sections of E12.5 Pax6−/−↔ Pax6+/+ chimeras indicated
lower densities of Pax6−/− cells in Pax6-expressing regions
than in Pax6 non-expressing regions. Fig. 1E shows an example
of this. The density of Pax6−/− cells (marked with dark dots) in
the Pax6-expressing hippocampus was lower than the density of
Pax6−/− cells in the cortical hem, in which the majority of cells
are Pax6 non-expressing (Fig. 1D).
The proportions of Tg+ cells in various tissues were then
quantified in these chimeras. Regions analyzed were Pax6-
expressing hippocampus, neocortex, dorsolateral ganglionic
eminence (dLGE) and Pax6 non-expressing midbrain and head
mesenchyme. If Pax6 status was neutral in terms of the
generation of cell number in these regions, we would expect the
percentages of Tg+ cells found in each structure in all
chimeras to be similar to the overall percentage of Tg+ cells
throughout the embryo; this expected percentage (designated
Fig. 2. Analysis of cell cycle characteristics using IdU/BrdU co-labeling. (A)
Injection at T0 h with IdU and T1.5 h with BrdU followed by sacrifice at T2.0 h
allows identification of three cell types: those within S-phase at T0–1.5 but
within G2/M at T1.5–2.0 (Lcells: IdU-labeled only—green in panels B–E); cells
entering S-phase at T1.5–2.0 (BrdU-labeled only—red in panels B–E); cells
within S-phase at both T0 and T1.5 (IdU/BrdU co-labeled—yellow in panels B–
E). By counting the numbers of cells in each of these three populations, cell
cycle characteristics can be determined as described in Methods. Cell cycle
characteristics were examined at E10.5 (B, C) and E12.5 (D, E) in wild-type (B,
D) and Pax6−/− (C, E) telencephalon. Scale bar=50 μm.
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The percentages of Tg+ cells observed in the structures
studied, corrected for sectioning artefact (Oc), were obtained
and the ratio Oc/E was calculated for each region analyzed
in each chimera (see Methods). As inclusion of the Tg
marker is developmentally neutral (West et al., 1996), we
would expect this ratio to be close to 1.0 in all structures in
Pax6+/+;Tg+↔Pax6+/+ chimeras and in structures that do not
normally express Pax6 in Pax6−/−;Tg+↔Pax6+/+ chimeras.
Mean Oc/E ratios (±SEMs, n=4 in all cases) are represented
in Fig. 1F and agree with this expectation. Mean Oc/E ratios
were significantly lower in hippocampus, neocortex and
dLGE in Pax6−/−;Tg+↔Pax6+/+ chimeras than in Pax6+/+;
Tg+↔Pax6+/+ chimeras (Fig. 1F).
Cell death is not increased early in corticogenesis in the
Pax6−/− neocortex
One possible explanation for the reduced size of the Pax6−/−
mutant cortex and the under-representation of Pax6−/− cells in
Pax6−/−↔Pax6+/+ chimeras was increased cell death. Although
previous studies found no increase in the proportions of
apoptotic cells in the cortex of Pax6−/− mutant embryos
(Estivill-Torrus et al., 2002; Fukuda et al., 2000; Lotto et al.,
2001; Warren et al., 1999), these studies were at later stages of
development. We found very few pyknotic cells in the E10.5–
E12.5 cortex of either (i) Pax6−/− embryos (Figs. 1A, B) or (ii)
Pax6−/−↔Pax6+/+ embryos (e.g., none are seen in Fig. 1E).
Since the proportion of dying cells at a given time depends on
clearance of cells from the tissue, which in this case is unknown
and may vary between genotypes, we carried out a further
comparison of viability in vitro, where clearance cannot occur.
There were no significant differences in the proportions of
apoptotic Pax6−/− and Pax6+/+ E12.5 neocortical cells after 24
h when the two types of cell were cultured either separately or
mixed in a 1:1 ratio. In the mixed cultures, percentages of
apoptotic cells identified (i) by nuclear morphology were 9.16%
(±0.55, SEM, n=4) among Pax6+/+ cells and 11.14% (±0.93
SEM, n=4) among Pax6−/− cells and (ii) by activated caspase-
3 were 7.75% (±0.77 SEM, n=4) among Pax6+/+ cells and
7.53% (±0.87 SEM, n=4) among Pax6−/− cells. Proportions of
apoptotic cells were also examined in cells acutely dissociated
from E12.5 neocortex of Pax6−/− and Pax6+/+ embryos by
staining with PI and using flow cytometry. The proportion of
cells in a sub-G1 peak (cells with a hypodiploid DNA content)
can be used to indicate the proportion of cells undergoing
apoptosis (Ormerod, 2000). Sub-G1 fractions were not sig-
nificantly different between Pax6−/− mutant and Pax6+/+ neo-
cortex (Pax6+/+ neocortex: 0.45%±0.13 SEM, n=4; Pax6−/−
neocortex: 1.43%±0.59 SEM, n=3, Student's t-test p=0.119).
Cell cycle length is not altered in E10.5 and E12.5 Pax6−/−
telencephalon
Under-representation of Pax6 mutant cells in the cortex of
Pax6−/−↔Pax6+/+ chimeras in the absence of increased cell
death among mutant cells increased the likelihood that theexplanation for the reduced production of Pax6−/− cells results
from a cell autonomous alteration in some aspect of their cell
cycle. Paradoxically, previous studies indicated that the cell
cycle of Pax6−/− telencephalic progenitors is abnormally rapid
at E12.5 (Estivill-Torrus et al., 2002; Warren et al., 1999), which
might increase cell production. We re-investigated cell cycle
length in the Pax6−/− telencephalon using a method illustrated
in Fig. 2A(Martynoga et al., 2005). Cell cycle lengths for wild-
type and mutant telencephalon are shown in Table 1. Consistent
with previous studies (Takahashi et al., 1995a), cell cycle
lengths increased between E10.5 and E12.5. At E10.5 similar
values for cell cycle length were observed in wild-type and
mutant dorsal telencephalon (Table 1, Figs. 2B, C). At E12.5, no
significant difference was observed in cell cycle length between
mutant and wild-type neocortex or hippocampus (Table 1; Figs.
Table 1
Average lengths (mean±SEM) of S-phase (Ts) and total cell cycle (Tc) for
Pax6+/+ and Pax6−/− telencephalon at E10.5 and E12.5 estimated by IdU/BrdU
double labeling method
Dorsal telencephalon Ts (h) Tc (h) Ts/Tc
E10.5
Pax6+/+ (n=2) 4.4 7.5 0.58
Pax6−/− (n=2) 5.0 8.6 0.58
Neocortex Ts (h)±SEM Tc (h)±SEM Ts/Tc±SEM
E12.5
Pax6+/+ (n=3) 5.8±0.78 11.9±1.69 0.48±0.22
Pax6−/− (n=4) 6.9±0.09 14.4±0.24 0.47±0.61
p= 0.15 0.24 0.61
Hippocampus
Pax6+/+ (n=3) 6.9±1.36 17.1±4.18 0.40±0.02
Pax6−/− (n=4) 7.3±0.45 16.5±1.04 0.44±0.03
p= 0.81 0.89 0.47
Data were compared using a Student's t-test to obtain p values.
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longer than in the neocortex of both mutant and wild-type
animals (Table 1). No significant differences were observed
between wild-type and mutant embryos in the ratio between the
length of S-phase and the entire cell cycle length (Ts/Tc) in
either hippocampus or neocortex (Table 1). The reasons why
this method gave a different outcome to that used previously
(Estivill-Torrus et al., 2002) are presented in Discussion. In any
case, neither this nor the previous estimates provide evidence
that a lengthening of the cell cycle is the cause of an under-
production of Pax6−/− cells.
Loss of Pax6 reduces S-phase re-entry and increases the
proportions of differentiating neurons
The most likely explanation remaining for a reduction in the
production of Pax6−/− telencephalic cells is premature with-
drawal of newborn cells from the cell cycle, causing an
increase in the proportion of differentiated cells with
concurrent depletion in the size of the progenitor pool.
Evidence that proportions of dividing cells exiting the cell
cycle were higher in Pax6−/− neocortex was obtained by
measuring the proportions of lightly and heavily BrdU-labeled
cells (Fig. 3A) in the ventricular zone after administering BrdU
to E12.5 embryos for either 30 min or continuously over
12.5 h. Immunocytochemical detection of the amount of BrdU
contained within cells is a well-established method for
monitoring progression through the cell cycle in flow cyto-
metry experiments (Ormerod, 2000). Similarly, previous
studies in tissue sections have shown that a pulse of BrdU
given to an animal results in cells with different relative levels
of BrdU labeling. Cells in S-phase at the time of the pulse
remain relatively heavily labeled unless they undergo sub-
sequent divisions, in which case their levels of BrdU are
diluted and their labeling becomes relatively lighter (del Rio
and Soriano, 1989; Gillies and Price, 1993; Price et al., 1997).
Here, the method was used as follows. After a short pulse of
BrdU, cells in S-phase and cells that had just left S-phasewould be detected by heavy labeling (Fig. 3B, example 1).
After longer pulses, a more lightly labeled population of cells
would emerge as cells carrying BrdU divide in M-phase and
distribute their BrdU load between their daughters (Fig. 3B,
example 2). The proportion of cells in the lightly labeled
population would increase with increasing length of BrdU
pulse until a maximum is reached as some cells re-enter S-
phase and incorporate more BrdU (Fig. 3B, example 3). We
predicted that if more cells become postmitotic in Pax6−/−
mutants than in wild-type embryos, then proportions of lightly
labeled cells would be higher in mutants after a continuous
12.5-h pulse of BrdU, which is long enough to allow
proliferating cells to re-enter S-phase. Our data are consistent
with this prediction (Figs. 3C–E). After a short pulse (0.5 h),
normal distributions of labeling intensity were obtained from
both genotypes (Fig. 3C). After longer pulses (12.5 h), both
Pax6+/+ and Pax6−/− embryos showed bimodal distributions,
but in the Pax6−/− embryos the proportions of lightly labeled
cells were higher than in Pax6+/+ embryos (Figs. 3D, E).
If more cells are exiting the cell cycle from E10.5–E12.5, we
predicted a corresponding increase in the proportion of
differentiated neurons in Pax6−/− telencephalon by E12.5. To
confirm this, we examined the expression of the early neuronal
marker β-III-tubulin in wild-type and Pax6−/− neocortex (Figs.
4A–C). We observed β-III-tubulin-expressing cells located
within the VZ of the mutant neocortex (Figs. 4B–C) and it
appeared that the proportions of β-III-tubulin-expressing cells
were increased, especially given the overall thinning of the
cortical wall (Figs. 4A, B). To quantify this, we dissociated
E12.5 cortical cells and counted the proportions ofβ-III-tubulin-
labeled and unlabeled cells. Manual counts showed a significant
increase (Student's t-test; p<0.025) in the proportions of β-III-
tubulin-expressing cells (mean=38.7%±3.4% SEM, n=3)
compared to Pax6+/+ neocortex (mean=23.2%±2.5% SEM,
n=3). This was confirmed using flow cytometry (Pax6−/−
neocortex: 29.43±1.68% SEM, n=3; Pax6+/+ neocortex;
19.15±1.21% SEM, n=5; Student's t-test p<0.005). Figs.
3D–F show representative flow cytometry plots demonstrating
this effect. It also reveals that the expression of this marker is
restricted mainly to cells with a diploid DNA content,
suggesting that β-III-tubulin expression within the cell cycle
is not significantly altered by loss of Pax6 expression.
DNA staining using PI in flow cytometry experiments
identified a significant decrease in the proportions of cells in
S-phase in Pax6−/− neocortex (Pax6+/+ neocortex; mean:
30.62%, ±1.09 SEM, n=5; Pax6−/− neocortex: 24.73%,
±1.31 SEM, n=3; Student's t-test p=0.011), consistent with
a relative depletion of the Pax6−/− mutant progenitor pool.
Thus, three lines of evidence using different techniques all
pointed to the conclusion that a larger proportion of cells exit
the cell cycle and differentiate in the absence of Pax6.
The transcription factor Tbr2 is downregulated in the Pax6−/−
neocortex
Microarray analysis was performed to screen for candidate
genes up- or downregulated in Pax6−/− neocortex (Faedo et al.,
Fig. 3. Assessment of proportions of cells exiting the cell cycle using cumulative BrdU labeling. (A) Section through the neocortex of an E12.5 Pax6+/+ embryo
showing BrdU-labeled cells after a 12.5-h pulse of BrdU-labeled cells are either heavily (closed arrowhead) or lightly labeled (open arrowhead). (B) Diagrammatic
representation of the cell cycle indicating how proportions of heavily and lightly labeled cells would vary for progressively longer pulses of BrdU. After a pulse shorter
than the length of time between S-phase and M-phase (example 1), a single population of heavily labeled cells would be identified (black circles). After a longer pulse
(example 2), a second population of labeled cells with a lower mean intensity of label would emerge as cells progress through M-phase (grey symbols). As the pulse
lengthens further (example 3) cells in the second, lightly labeled population would either re-enter S-phase and replenish their BrdU load and become heavily labeled or
would exit the cell cycle, enter G0 and remain lightly labeled. (C–E) Graphs illustrate frequency distributions for intensity of BrdU label in cells in histological sections
after pulses of BrdU lasting (C) 0.5 h and (D, E) 12.5 h in wild-type (C, D) and mutant (C, E) neocortex. Each set of differently shaded bars corresponds to an
individual animal. (C) At 0.5 h in both mutant and wild type all cells are heavily labeled with BrdU. (D, E) After a 12.5-h pulse with BrdU, heavily and lightly labeled
cell populations can be identified but more lightly labeled cells are present in the mutant (E) than in wild type (D).
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the T-domain containing transcription factor Tbr2 (Bulfone et
al., 1999; Kimura et al., 1999) (downregulated by a factor of
2.52). Downregulation of Tbr2 protein was confirmed earlier, at
E12.5, as well as at E14.5 in total protein isolated from Pax6+/+
and Pax6−/− neocortex (Fig. 5A).
Tbr2 is expressed in both postmitotic neurons and BPCs in
the dorsal telencephalon (Englund et al., 2005). Localization of
Tbr2 protein in Pax6−/− mutant and wild-type neocortex was
compared (Figs. 5B–G). In wild-type E12.5 dorsal telencepha-
lon, Tbr2-expressing cells were found mainly in the preplate
with some in the proliferative zone (Fig. 5B,D) in a highlateral to
lowmedial density gradient (Fig. 5B). This distribution of Tbr2-
labeled cells closely mirrors expression of Pax6 in the
ventricular zone (Fig. 1A; see also Englund et al., 2005). In
the E12.5 Pax6−/− cortex, almost all Tbr2-expressing cells
were in the preplate (Figs. 5C, E) and very few were in the
underlying proliferative zone. The highlateral to lowmedialgradient of Tbr2-expressing cells was lost (Fig. 5C); this was
confirmed by quantitation of Tbr2-expressing cell density (Fig.
5G). The gradient was flattened: there was a small but
significant increase in the number of Tbr2-expressing cells in
the mutant hippocampus while lateral cortical regions showed
large reductions in the number of Tbr2-expressing cells (Fig.
5G). These changes were not explained by overall differences
in total cell densities between wild-type and mutant telence-
phalon in any area examined (Fig. 5F). Thus, expression of
Tbr2 is strongly downregulated in the proliferative cells of
mutants.
Examining the nature of Tbr2-expressing cells in Pax6−/−
neocortex
To determine the nature of the Tbr2-expressing cells in
mutant embryos, we first examined expression of a marker of
early postmitotic neurons, β-III-tubulin. In the differentiating
Fig. 4. Precocious neurogenesis in the E12.5 Pax6−/− telencephalon. β-III-tubulin expression in (A) wild-type and (B, C) Pax6−/− neocortex. (A) In wild-type
telencephalon at E12.5, β-III-tubulin-expressing cells are present in the preplate. (B) In Pax6−/− telencephalon, β-III-tubulin-expressing neurons can be observed both
in the preplate and abnormally located within the ventricular zone (white arrowheads in panel C). (C) Enlargement of area outlined in panel B. (D–F) Flow cytometric
analysis of β-III-tubulin expression in dissociated (E) Pax6+/+ and (F) Pax6−/− E12.5 neocortical cells. (D) No primary (NP) control reaction: gating was established
(boxed region in panels D–F) by PI staining for cells containing a diploid DNA content (cells in G1/G0). Plots shown are from a single representative experiment for
each genotype. The proportion of cells expressing β-III-tubulin are within the boxed region. (F) Pax6−/− neocortex shows an increase in the number of β-III-tubulin-
expressing neurons. Scale bars= (A, B) 80 μm; (C)=40 μm.
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rons were either Tbr2-expressing or Tbr2-non-expressing (Fig.
6A). This is consistent with the previous description of up
regulation of Tbr2 in early postmitotic neurons and subsequent
downregulation of Tbr2 in these cells as neuronal differentia-
tion proceeds (Englund et al., 2005). Cells of both types were
also seen in the Pax6−/− preplate (Fig. 6B). Beneath the
preplate of wild types, many Tbr2-expressing, β-III-tubulin-
non-expressing cells were present and, as previously described,
had condensed chromatin indicative of cells undergoing
mitosis, confirming them as BPCs (Englund et al., 2005)
(Fig. 6A). Beneath the preplate in Pax6−/− cortex, most of the
small number of Tbr2-expressing cells were also β-III-tubulin-
positive (Fig. 6B), suggesting these cells are mislocated Tbr2-
expressing neurons rather than Tbr2-positive BPCs. No Tbr2-
positive mitotic figures were observed in mutants.
As Tbr2 is normally expressed in BPCs (Englund et al.,
2005), we wanted to determine whether actively cycling Tbr2-
expressing cells were present in mutant embryos. A short (2 h)
pulse of BrdU was given at E12.5 to label cells during S-phase
of the cell cycle (Figs. 6C, D). In wild-type cortex, co-
localization of Tbr2 with BrdU was observed frequently in
BPCs in all sections through the basal proliferative zone and
preplate (Fig. 6C). In contrast, we observed very few BrdU/Tbr2-expressing cells in Pax6−/− cortex; Fig. 6D shows two
examples but most sections contained none. These data
indicated either that BPCs do not exist in significant numbers
in Pax6−/− mutants or that cells dividing non-apically do not
express Tbr2 in mutants.
Pulse labeling with BrdU does not distinguish clearly
between APCs and BPCs, both of which undergo S-phase in
a similar location. Therefore, we examined co-expression of
the mitotic marker phosphohistone-3 (pH3) and Tbr2 (Fig. 7).
pH3 is expressed strongly in cells undergoing late G2/M-
phase and is used as a marker of mitosis in cycling cell
populations (Scott et al., 2004; Scott et al., 2003). In wild-
type neocortex, two pH3-expressing cell populations were
observed: (1) pH3-expressing/Tbr2 non-expressing APCs
located at the apical ventricular surface; and (2) pH3-
expressing/Tbr2-expressing BPCs located in the basal pro-
liferating zone (Figs. 7A, C–E). In wild-type neocortex, all
non-apically located pH3-expressing cells were Tbr2 expres-
sing (Figs. 7A, C–E) consistent with the reported expression
of Tbr2 in this proliferative population (Englund et al., 2005).
In Pax6−/− cortex (Figs. 7B, F–H), as in wild-type animals,
pH3-expressing cells at the apical ventricular surface were
always Tbr2-non-expressing. Cells expressing pH3 were also
seen at non-apical locations, as in wild-type animals, but the
Fig. 5. The transcription factor Tbr2 is downregulated in the Pax6−/−
telencephalon. (A) Western blot for Tbr2 protein from E12.5 and E14.5 cortex
of Pax6+/+ and Pax6−/− embryos. A significant reduction in Tbr2 protein is
observed in the homozygous mutant lateral cortex at both E12.5 and E14.5. (B–
E) Tbr2 localization in Pax6+/+ (B, D) and Pax6−/− (C, E) telencephalon at
E12.5. In Pax6+/+ telencephalon, Tbr2-expressing cells are located in the
preplate (pp) and within the ventricular and subventricular zone (vz). In the
Pax6−/− telencephalon, almost all Tbr2-expressing cells are present in the
preplate. (F) Quantification of telencephalic cell density and (G) Tbr2-
expressing cell density in hippocampus (h), dorsal cortex (dcxt), central
neocortex (cctx) and lateral neocortex (lctx) (boxed areas in panel B) at E12.5 in
Pax6+/+ (open bars) and Pax6−/− mutant (filled bars) telencephalon. (F) No
significant difference is observed in cell density between mutant and wild-type
animals in any telencephalic region examined. (G) A significant increase is
observed in the density of Tbr2-expressing cells present in the Pax6−/−
hippocampus and a significant decrease in the densities observed in the Pax6−/−
central neocortex and lateral neocortex compared to wild types. Significant
differences (Student's t-test, p<0.05) are marked with an asterisk (*).
Fig. 6. Tbr2-expressing postmitotic neurons are present in the Pax6−/−
telencephalon. (A) In the proliferative layer of E12.5 wild-type neocortex,
Tbr2 labels cells that are β-III-tubulin negative (red arrowheads). Some of
these cells appear to be dividing indicating they are BPCs (red arrowhead
containing white m). In the preplate, Tbr2/β-III-tubulin co-expressing
postmitotic neurons are observed (yellow arrowhead) as well as β-III-
tubulin-expressing neurons which are down regulating or have down regulated
Tbr2 expression (white arrowhead). (B) In the proliferative layer of E12.5
Pax6−/− neocortex, many Tbr2-positive cells are β-III-tubulin-positive (yellow
arrowheads) while some are not (red arrowhead). In the preplate, co-
expressing (yellow arrowhead) and β-III-tubulin-positive/Tbr2 negative (white
arrowhead) cells are seen. (C, D) A 2-h BrdU pulse was used to label cells
that are actively cycling in the E12.5 Pax6+/+ and Pax6−/− telencephalon. (C)
In Pax6+/+ telencephalon, Tbr2/BrdU co-labeled BPCs can be observed in the
basal ventricular zone and preplate (white arrowheads). (D) In the Pax6−/−
telencephalon, very few of the BrdU-labeled cells express Tbr2 (white
arrows). Scale bars: (A, B)=20 μm; (C, D)=40 μm.
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labeled cell is shown in (Figs. 7F–H), but all other sections
showed none. Thus, the early Pax6−/− cortex contains a
population of cells undergoing abventricular mitoses in the
location where BPCs are found in wild-type cortex, but
hardly any express Tbr2.Some cortical cells undergoing abventricular mitoses in
Pax6−/− embryos express the ventral marker Mash1
Abventricular mitoses occur with high frequency in normal
ventral telencephalon (Sheth and Bhide, 1997), which does
not express Tbr2 but does express the transcription factor
Mash1 (Fig. 8A) (Guillemot and Joyner, 1993; Lo et al.,
1991). Many dividing pH3-positive cells in the wild-type
lateral ganglionic eminence express Mash1 (Figs. 8C, E, G).
Ectopic dorsal expression of normally ventrally restricted
Mash1 mRNA has been reported in Pax6−/− mutants (Kroll
and O'Leary, 2005; Muzio et al., 2002a; Muzio et al., 2002b;
Stoykova et al., 2000; Toresson et al., 2000). We confirmed
that Mash1 protein is expressed in many cells in the Pax6−/−
cortex (Fig. 8B); this ectopic expression does not co-localize
with Tbr2 expression in the preplate. In many sections
Fig. 7. Few abventricular mitoses express Tbr2 in Pax6−/− mutant telencephalon. Immunohistochemistry for Tbr2 and phosphohistone-3 (pH3) in panels A, C–E
Pax6+/+ and (B, F–H) Pax6−/− E12.5 telencephalon. pH3 labels mitotic cells in late G2/M-phase. (A, C–E) In wild-type telencephalon, cells strongly reactive for pH3
can be observed both at the apical ventricular surface (avs) and within the basal ventricular zone (bvz); all pH3-expressing cells observed in the bvz are also Tbr2-
expressing (yellow arrowheads in panels C–E). (B, F–H) In the Pax6−/− neocortex, there are very few BPCs expressing both Tbr2 and pH3 (yellow arrowhead). In
contrast, many pH3-expressing, Tbr2-non-expressing cells (light blue arrowheads) are present within the proliferating zone. Scale bars (A, B)=100 μm, (C–H)=80 μm.
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tricular mitoses expressing Mash1 (Figs. 8D, F, H) suggesting
at least a partial transformation of the population of
abventricularly dividing cells to a ventral telencephalic
character.
Pax6 is required cell autonomously in cortex for expression of
Tbr2 and repression of genes normally expressed in the lateral
ganglionic eminence
In normal mice, Pax6 is downregulated in cells expressing
Tbr2 (Englund et al., 2005), raising the question of whetherTbr2 expression in cortical cells requires (i) Pax6 expression
in the same cells at an earlier time (i.e., a cell autonomous
requirement) or (ii) signals from nearby Pax6-expressing
cells (i.e., a cell non-autonomous requirement). To distin-
guish between these possibilities we examined Tbr2 expres-
sion in Pax6−/− cells that were mixed with wild-type cells in
Pax6−/−↔Pax6+/+ chimeras; Pax6−/− cells were identified
by the presence of signal for the β-globin transgene (see
Methods; Quinn et al., 1996; Talamillo et al., 2003). We
observed many small clusters of Pax6−/− cells intermingled
with and surrounded by wild-type cells expressing Tbr2 (Figs.
9A, B). Almost all Pax6−/− cells were negative for Tbr2 (Figs.
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progenitor cells for their normal expression of Tbr2.
We then tested whether cells lacking Pax6 in Pax6−/−↔
Pax6+/+ chimeras upregulate genes whose expression is
normally restricted ventrally in the telencephalon (Fig. 9). We
found that most Pax6−/− cortical cells in chimeras express
Mash1 (Fig. 9C), Gsh2 (Figs. 9E, F) and Dlx2 (Figs. 9G–I).
Wild-type cortical cells in chimeras do not express these genes
(Figs. 9C, E, I), indicating that the presence of mutant cells doesnot induce expression in wild-type cells. In the ventral
telencephalon of chimeras, Mash1, Gsh2 and Dlx2 are
expressed by cells of both genotypes (seen for Mash1 in Fig.
9D). Nkx2.1 is also expressed by cells of both genotypes in the
proliferative zone and around the internal capsule in the medial
ganglionic eminence (Fig. 9J) but not by Pax6−/− cells in the
cortex of chimeras (Fig. 9K). We observed the lack of Tbr2
expression and activation of Mash 1, Gsh2 and Dlx2 (and not
Nkx2.1) expression in the Pax6−/− cells of chimeras throughout
the full extent of the cortex, including its most medial regions.
Fig. 10 shows examples of the absence of Tbr2 and expression
of Mash1 in mutant cells in the hippocampus of chimeras. We
conclude that Pax6 has cell autonomous actions within the
cortical cells expressing it to activate expression of Tbr2 and to
repress expression of genes normally expressed in the lateral
ganglionic eminence.
Discussion
Our aim was to use in vivo methods to study early defects in
cortical cells lacking Pax6 so as to obtain a clearer picture of the
likely primary cell autonomous actions of this transcription
factor. Previous studies have demonstrated that, from the onset
of corticogenesis, Pax6−/− cells have a cell autonomous defect
in their adhesion properties (Stoykova et al., 1997; Talamillo et
al., 2003; Tyas et al., 2003). It is less clear how many of the
other cortical defects that have been reported in Pax6−/−
mutants reflect cell autonomous, rather than indirect cell non-
autonomous, requirements for Pax6 in the affected processes.
Our results indicate that Pax6 is required cell autonomously to
regulate the production of correct numbers of dorsal tele-
ncephalic cells with the correct identities.
Pax6 reduces cell cycle exit among early cortical progenitors
Our conclusion that Pax6−/− cells exit the cell cycle in
abnormally large numbers at the onset of corticogenesis rests on
evidence from multiple experimental approaches. We showed
that, early in corticogenesis, newly divided progenitors do not
re-enter S-phase in normal numbers and that there is a
corresponding increase in proportions of neurons and reduction
in proportions of cortical cells in S-phase. A reduction in size ofFig. 8. Mash1 is ectopically expressed in some Pax6−/− neocortical abventricular
mitotic cells. (A) At E12.5 in Pax6+/+ telencephalon, Mash1 is restricted to the
ganglionic eminences (lge, lateral ganglionic eminence), abutting Tbr2
expression in the developing neocortex (lctx, lateral cortex) at the pallial–
subpallial boundary. (B) In E12.5 Pax6−/− telencephalon, many cells throughout
the cerebral cortex (ctx) express Mash1. Tbr2-expressing cells of the mutant
preplate do not express Mash1. (C) In E14.5 Pax6+/+ telencephalon, Mash1
expression is restricted to the ganglionic eminences. (D) In E14.5 Pax6−/−
telencephalon, dorsal and ventral telencephalic cells express Mash1. (E,G)
Abventricular mitoses in the lateral ganglionic eminence of Pax6+/+
telencephalon express Mash1 (yellow arrows; panel G is the same field as
panel E in green channel alone). (F, H) Most pH3-expressing cells undergoing
mitosis in abventricular locations in the Pax6−/− neocortex do not express
Mash1 (red arrows); a minority of these cells do express low levels of Mash1
(yellow arrows; panel H is the same field as panel F in the green channel
alone). Scale bars (A, B)=80 μm; (C, D)=160 μm; (E–H)=40 μm.
Fig. 9. Pax6 is required cell autonomously for Tbr2 expression and repression of lateral ganglionic eminence markers in cortical cells. (A, B) Sections of cortex of
Pax6−/−↔Pax6+/+ chimera double-labeled for Tbr2 protein (green) and Pax6−/− cells (red dots resulting from DNA–DNA in situ hybridization to a reiterated β-globin
transgene, β-glb). Most Pax6−/− cells do not express Tbr2 (Panel A, rostral section; Panel B, central section). (C, D) Sections of cortex (C) and lateral ganglionic
eminence (D) of Pax6−/−↔Pax6+/+ chimera double-labeled forMash1 protein (grey) and Pax6−/− cells (brown dots). In cortex, Mash1 expression is in Pax6−/− cells but
not in wild-type cells. In the lateral ganglionic eminence, Mash1 is expressed in both wild-type and Pax6−/− cells. (E, F) Sections of rostral (E) and caudal (F) cortex of
Pax6−/−↔Pax6+/+ chimera double-labeled for Gsh2 protein (grey) and Pax6−/− cells (brown dots). Gsh2 expression coincides with the Pax6−/− cells. (G) Dlx2-positive
cells in the cortex of a Pax6−/−↔Pax6+/+ chimera. (H) Dlx2-positive cells in the lateral ganglionic eminence (lge), medial ganglionic eminence (mge) and cortex (ctx) of
a Pax6−/−↔Pax6+/+ chimera; (I) Dlx2-positive cells in the cortex are Pax6−/− (i.e., Tg-positive). (J) Nkx2.1-positive cells in the medial ganglionic eminence (mge) and
around the internal capsule (ic) of a Pax6−/−↔Pax6+/+ chimera; (K) Pax6−/− (Tg+) cortical cells are Nkx2.1-negative. Scale bars: (A, B, G, K) = 40 μm; (C–F, I)=
20 μm; (H, J)=60 μm.
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underproduction of mutant cells and the reduced size of the
mutant cortex. Further evidence supporting this conclusion
came from experiments to exclude other possible explanations
for underproduction of mutant cells, namely increased cell death
and lengthening of the cell cycle.
These findings provide a possible explanation for results
described in the study by Heins et al. (2002) which showed that
cortical radial glial cells (or APCs) isolated from older, E14,
Pax6−/− embryos have a reduced neurogenic potential. Theyfound that proportions of radial glial progenitors and post-
mitotic neurons were abnormally low in Pax6−/− embryos at
this later age. This is readily explained by premature exit of
progenitors from the cell cycle and the consequent depletion of
the neurogenic progenitor pool during the preceding days. In
addition, Heins et al. (2002) showed that those radial glial
progenitors that are present at E14 produce abnormally small
numbers of neuronal clones in vitro, suggesting that their
neurogenic potential has altered. This might be a direct
consequence of the lack of Pax6 in these progenitors.
Fig. 10. Pax6−/− cells in the medial regions of the cortex downregulate Tbr2 and upregulate ventral telencephalic markers. (A) Hippocampus of Pax6−/−↔Pax6+/+
chimera double-labeled for Tbr2 protein (green) and Pax6−/− cells (red dots, as in Fig. 9). (B) Hippocampus of Pax6−/−↔Pax6+/+ chimera double-labeled for Mash1
protein (grey) and Pax6−/− cells (brown dots). Scale bar=20 μm.
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to a change in the size of the radial progenitor population
altering cell–cell signaling between progenitors and redefining
their developmental fates.
Interestingly, an increase in the proportion of reelin-
expressing cells has been reported in the Pax6−/− mutant cortex
at E14.5 (Stoykova et al., 2003). Reelin-expressing cells are
derived from the earliest postmitotic cells of the neocortex.
Again, this finding is compatible with our results: an increased
production of postmitotic neurons early in corticogenesis
followed by a reduced production later on could explain an
increased proportion of reelin-expressing cells by E14.5. Our
findings in the cortex have a parallel in the eye, where loss of
Pax6 results in precocious neuronal differentiation in the early
optic stalk (Philips et al., 2005).
In a previous study we concluded that cell cycle length in
the developing E12.5 cortex is shorter than normal in the
Pax6−/− mutant (Estivill-Torrus et al., 2002). An alternative
method for analyzing cell cycle length used here indicates that
cell cycle lengths are not altered significantly at E10.5 and
E12.5 in Pax6−/− mutants. Importantly, neither study suggests a
lengthening of the cell cycle at these ages, an outcome which
might have provided an alternative explanation for under-
production of mutant cells. Nevertheless, it is interesting to
consider the possible reasons for the discrepancy between the
methods. It is most likely that the earlier study overestimated the
reduction in cell cycle times in Pax6−/− mutants. Estivill-Torrus
et al. (2002) used the cumulative BrdU incorporation paradigm
(Nowakowski et al., 1989), in which BrdU is administered to a
cohort of animals for progressively longer periods of time until
all progenitors have taken it up. This time is a critical measure in
this method (Nowakowski et al., 1989; Takahashi et al., 1995a)
and, in common with others who have studied cell cycle timesin wild-type cortex, Estivill-Torrus et al. (2002) estimated it by
extrapolation using linear regression on data for the proportions
of labeled cells after 3–4 BrdU pulses of increasing lengths. Re-
analysis of those data using non-linear regression in mutants,
which is appropriate if the progenitor cell cycle times are more
heterogeneous in mutants (Nowakowski et al., 1989; Takahashi
et al., 1995a), gives cell cycle times much closer to wild-type
values (as little as 10% different, as opposed to the 40%
difference reported by Estivill-Torrus et al., 2002). An
interesting inference from this is that cells in the progenitor
pool of Pax6 −/− mutant cortex are likely to be more
heterogeneous in their cell cycle times, as they are in their
abnormal expression of Mash1, which is present in only some
mitotic cells.
Pax6 regulates cell autonomously the identity of dorsal
telencephalic progenitors
Pax6 is required for two major features of dorsal telen-
cephalic cell identity, namely the suppression of ventral gene
expression and the production of a normal population of Tbr2-
expressing BPCs. Previous studies have shown that the cerebral
cortex of Pax6−/− mutants becomes progressively ventralized
during the second half of gestation, with increasing proportions
of cortical cells expressing markers typical of ventral tele-
ncephalic cells (Stoykova et al., 2000; Toresson et al., 2000;
Yun et al., 2001; Kroll and O'Leary, 2005). Kroll and O'Leary
(2005) showed that this ventralization is due to a change in the
fates of cells generated from the cortical proliferative zone.
Whether this fate change is induced in cortical cells by defects
in interacting cells lacking Pax6 or whether it reflects a cell
autonomous requirement for Pax6 for the suppression of ventral
fates within cortical cells was not clear. Our data indicate that
63J.C. Quinn et al. / Developmental Biology 302 (2007) 50–65the defective identities of mutant cortical cells reflect cell
autonomous requirements for Pax6 within them. Moreover, the
autonomously affected mutant cells were not able to induce
expression of ventral markers in surrounding wild-type cells.
We conclude that the presence of Pax6 within wild-type cortical
cells is necessary to suppress their expression of lateral
ganglionic eminence genes. It is not, however, required to
prevent their expression of the medial ganglionic eminence
marker, Nkx2.1; loss of Pax6 is not sufficient to activate Nkx2.1
expression in dorsal telencephalic cells.
Englund et al. (2005) showed that cortical BPCs express
Tbr2 but downregulate Pax6. Cortical BPCs give rise to
neurons (Haubensak et al., 2004; Miyata et al., 2004; Noctor et
al., 2004) and there is evidence that the superficial layers are
generated by these neurons (Tarabykin et al., 2001). Previous
studies in Pax6−/− mutants have shown downregulation of
expression of a variety of molecules normally expressed in
cortex, including R-cadherin and Svet1 (Stoykova et al., 1997;
Tarabykin et al., 2001). In the present study, we identified a loss
of Tbr2 in cells deep to the cortical plate, a population that
includes cells undergoing abventricular mitoses which would
normally express Tbr2 (i.e., BPCs). It is likely that Pax6−/−
BPCs are not correctly specified. Interestingly, whereas Pax6 is
required cell autonomously to generate a normal population of
Tbr2-expressing BPCs, Caric et al. (1997) showed that E16
Pax6−/− cortical cells transplanted into a wild-type environment
were able to contribute in large numbers to the superficial
layers. The function of Tbr2 in cortical development is not clear
but it is possible that expression of neither Pax6 nor Tbr2 is
required within cortical progenitors for them to generate
neurons capable of populating the superficial layers. More
likely, these genes may be required to specify the types of cells
produced rather than their locations.
The differential expression of transcription factors confers
different regional characteristics to progenitor cells in both
dorsal and ventral telencephalon (Zaki et al., 2003). Pax6 plays
a significant role in regionalization of the developing
telencephalon both prior to and during corticogenesis (Bishop
et al., 2000; Muzio et al., 2002a; Toresson et al., 2000; Yun et
al., 2001). In the developing neocortex, regional differences in
cell proliferation may underlie regional differences in the
cortical areas produced (Polleux et al., 1997). Tbr2 is expressed
at different levels in different parts of the wild-type cortex,
exhibiting a matching highlateral to lowdorsal gradient of
expression to that of Pax6 (present results; Englund et al.,
2005). We found that loss of Pax6 expression causes loss of
graded Tbr2 expression, the greatest loss occurring in the lateral
cortex of the Pax6−/− mutant telencephalon, where Pax6 is
most highly expressed in the wild-type embryo. It seems likely
that loss of graded Tbr2 expression contributes to the loss of
cortical regionalization observed in the late-gestation Pax6−/−
embryo (Bishop et al., 2000; Muzio et al., 2002a).
Conclusions
Our findings point to three early cell autonomous roles for
Pax6 in developing cortex: (i) maintenance of the size of thecortical progenitor pool; (ii) activation of Tbr2 expression; (iii)
repression of genes normally expressed ventrally, in the lateral
ganglionic eminence. We suggest that Pax6 is required cell
autonomously to keep dorsal telencephalic progenitor cells in
the cell cycle and maintain their dorsal identities.
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